PTAB Weighs Sanofi Insulin Pen Patents In Mylan IP Row
The Patent Trial and Appeal Board asked tough questions about the role of injection force during six consolidated inter partes reviews Wednesday in Mylan's effort to knock out several Sanofi-Aventis patents...To view the full article, register now.
Already a subscriber? Click here to view full article